The Cal-DSH diversion guidelines.


Journal

CNS spectrums
ISSN: 1092-8529
Titre abrégé: CNS Spectr
Pays: United States
ID NLM: 9702877

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 28 10 2020
pubmed: 29 10 2020
medline: 4 9 2021
Statut: ppublish

Résumé

The Cal-DSH Diversion Guidelines provide 10 general guidelines that jurisdictions should consider when developing diversion programs for individuals with a serious mental illness (SMI) who become involved in the criminal justice system. Screening for SMI in a jail setting is reviewed. In addition, important treatment interventions for SMI and substance use disorders are highlighted with the need to address criminogenic risk factors highlighted.

Identifiants

pubmed: 33111661
doi: 10.1017/S1092852920001819
pii: S1092852920001819
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

701-713

Auteurs

Michael A Cummings (MA)

California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA.

Charles Scott (C)

Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento, California 95817, USA.

Juan Carlos Arguello (JC)

California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95816, USA.

Ai-Li W Arias (AW)

California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA.

Ashley M Breth (AM)

California Department of State Hospitals, Forensic Services Division, Sacramento, California 95816, USA.

Darci Delgado (D)

California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA.

Phil D Harvey (PD)

Miller School of Medicine, University of Miami, Miami, Florida 33136, USA.

Jonathan M Meyer (JM)

California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA.

Jennifer O'Day (J)

California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Metropolitan, Norwalk, California 90650, USA.

Megan Pollock (M)

California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA.

George Proctor (G)

California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Patton, Patton, California 92369, USA.

Tiffany Rector (T)

California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA.

Benjamin Rose (B)

California Department of State Hospitals, DSH-Napa, Napa, California 94558, USA.

Eric Schwartz (E)

California Department of State Hospitals, Psychopharmacology Resource Network, DSH-Napa, Napa, California 94558, USA.

Helga Thordarson (H)

California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95814, USA.

Katherine Warburton (K)

California Department of State Hospitals, Clinical Operations Division, Sacramento, California 95816, USA.

Stephen M Stahl (SM)

California Department of State Hospitals, Psychopharmacology Services, Sacramento, California 95814, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH